The UK Intellectual Property Office (UKIPO) has announced proposed fee increases averaging 25% across trade marks, patents, and designs, subject to parliamentary approval These changes would… read more…
The UK Intellectual Property Office (UKIPO) has proposed fee increases, averaging around 25%, across trade marks, designs and patents, with changes expected to take effect on 1 April 2026, subject… read more…
Gene therapy is revolutionising the field of molecular medicine and the capabilities of therapeutic approaches Recent developments demonstrate the potential for gene therapy to address some of… read more…
Three Mathys & Squire Partners, Anna Gregson, Dani Kramer, and Martin MacLean, have been recognised in the 2026 edition of IAM Strategy 300 Global Leaders The guide acknowledges those that… read more…
Partner Samantha Moodie and Associate Clare Pratt have been featured in Life Sciences IP Review and Aesthetic Medicine providing commentary on the increased use of biotherapeutic molecules in… read more…
On the 13th of November, author Ruth Leigh came to our London office in the Shard to join us for this month’s book club and give a talk about her career journey Ruth previously worked at… read more…
We are delighted to be the Forum Partner for ELRIG’s UK Forum “Outside the norm”, an event at the University of Warwick, Coventry, exploring engineering biology for drug discovery Partner Martin… read more…
IPSS Electra Valentine has co-written an article in response to Black History Month, discussing the notion of ‘professionalism’ at work and how we must separate it from Eurocentric standards The… read more…
Partner Claire Breheny has been featured in ‘New non-alcoholic cocktail brands rise by 19% in two years’ by The Morning Advertiser, ‘Sober curious: How no and low alcohol drinks are redrawing legal… read more…